1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. SYNLAB AG
  6. News
  7. Summary
    SYAB   DE000A2TSL71

SYNLAB AG

(SYAB)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 05/20 03:58:02 pm
16.735 EUR   +1.18%
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SYNLAB : Deutsche Bank remains its Buy rating

12/07/2021 | 06:51am EDT

In his latest research note, analyst Jan Koch confirms his positive recommendation. The broker Deutsche Bank is keeping its Buy rating. The target price is unchanged at EUR 26.


© MarketScreener with dpa-AFX Analyser 2021
All news about SYNLAB AG
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10SYNLAB AG : SYNLAB Medical Congress: making healthcare future-proof with advanced diagnost..
EQ
More news
Analyst Recommendations on SYNLAB AG
More recommendations
Financials
Sales 2022 3 163 M 3 337 M 3 337 M
Net income 2022 309 M 326 M 326 M
Net Debt 2022 1 508 M 1 591 M 1 591 M
P/E ratio 2022 11,7x
Yield 2022 1,82%
Capitalization 3 709 M 3 913 M 3 913 M
EV / Sales 2022 1,65x
EV / Sales 2023 1,75x
Nbr of Employees 25 750
Free-Float 75,7%
Chart SYNLAB AG
Duration : Period :
SYNLAB AG Technical Analysis Chart | SYAB | DE000A2TSL71 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 16,69 €
Average target price 22,49 €
Spread / Average Target 34,7%
EPS Revisions
Managers and Directors
Mathieu Olivier Floreani Chairman-Management Board & CEO
Sami Badarani Chief Financial Officer
David Raymond Ebsworth Chairman-Supervisory Board
Santiago Valor Garcia Chief Medical Officer
Henrik Andreasen Chief Information Officer
Sector and Competitors